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ABSTRACT
Introduction: Type 1 diabetes (T1D) in children and
adolescents is increasing worldwide with a particular
increase in children <5 years. Fewer than 1 in 6
children and adolescents achieve recommended
glycated hemoglobin (HbA1c) values.
Methods: A pragmatic, cluster-randomized controlled
trial assessed the efficacy of a clinic-based structured
educational group incorporating psychological
approaches to improve long-term glycemic control,
quality of life and psychosocial functioning in children
and adolescents with T1D. 28 pediatric diabetes
services were randomized to deliver the intervention or
standard care. 362 children (8–16 years) with
HbA1c≥8.5% were recruited. Outcomes were HbA1c at
12 and 24 months, hypoglycemia, admissions, self-
management skills, intervention compliance, emotional
and behavioral adjustment, and quality of life. A
process evaluation collected data from key stakeholder
groups in order to evaluate the feasibility of delivering
the intervention.
Results: 298/362 patients (82.3%) provided HbA1c at
12 months and 284/362 (78.5%) at 24 months. The
intervention did not improve HbA1c at 12 months
(intervention effect 0.11, 95% CI −0.28 to 0.50,
p=0.584), or 24 months (intervention effect 0.03, 95%
CI −0.36 to 0.41, p=0.891). There were no significant
changes in remaining outcomes. 96/180 (53%) families
in the intervention arm attended at least 1 module. The
number of modules attended did not affect outcome.
Reasons for low uptake included difficulties organizing
groups and work and school commitments. Those with
highest HbA1cs were less likely to attend. Mean cost of
the intervention was £683 per child.
Conclusions: Significant challenges in the delivery of
a structured education intervention using psychological
techniques to enhance engagement and behavior
change delivered by diabetes nurses and dietitians in
routine clinical practice were found. The intervention
did not improve HbA1c in children and adolescents
with poor control.
Trial registration number: ISRCTN52537669,
results.
BACKGROUND
Type 1 diabetes (T1D) is a common chronic
condition in which control of glycemia in
Key messages
▪ The CASCADE intervention was not able to dem-
onstrate improved diabetes control in children
and adolescents with poor glycemic control
when delivered in routine National Health Service
(NHS) care by specialist clinic staff given 2 days
standardized training.
▪ Despite evidence that the intervention was
popular with staff and with families that attended,
there were significant challenges in the organiza-
tion and delivery of groups alongside standard
practice that are often not acknowledged.
▪ Interventions need to be tailored to the specific
needs of children and families and may need
greater flexibility in delivery and more specialist
staff. The challenges in the ability to deliver struc-
tured education and the failure to provide any
measurable benefits to children and young people
or their parents that received the intervention has
important implications for clinical practice and
national policy.
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childhood and adolescence is strongly predictive of later
diabetic complications.1 Yet the majority of children and
adolescents with T1D have poor glycemic control, even
in high-income countries.2 In the UK <16% of children
and adolescents have an glycated hemoglobin (HbA1c)
below 7.5% (<58 mmol/mol), the recommended target
for prevention of long-term complications,3 despite the
widespread use of intensive insulin regimens and
growing use of insulin pumps.
The ineffectiveness of intensive insulin regimens in
improving population childhood diabetes control has
focused attention on other factors including self-
management skills, adherence behaviors and psychosocial
adjustment.4 5 A key health system factor identiﬁed as pro-
moting good childhood diabetes control is the provision of
diabetes education involving families.6 Structured standar-
dized diabetes education programmes have been shown to
improve glycemic control in adults with T1D.7 8 Although
delivery of a structured diabetes education programme is a
requirement for specialist funding of pediatric diabetes ser-
vices in England9 and in Germany, there is no evidence
from randomized controlled trials to support the effective-
ness of structured education for improving diabetes
control in children and adolescents. Currently, standard
care in UK clinics does not include any evidence-based
structured education programmes.
In contrast, pilot studies suggest that motivational
interviewing (MI) and solution-focused brief therapy
(SF) show efﬁcacy in reducing HbA1c, fear of hypogly-
cemia and improving quality of life (QOL) and positive
well-being.10–17 We undertook a large cluster-
randomized pragmatic trial of a structured education
programme for child and adolescent diabetes that incor-
porated MI and SF components, funded by the National
Institute of Health Research (NIHR) Health Technology
Assessment Programme. The protocol has been previ-
ously reported.18
METHODS
Intervention
The Child and Adolescent Structured Competencies
Approach to Diabetes Education (CASCADE) interven-
tion is a manual-based four-module structured education
programme which uses solution focused and motiv-
ational approaches to increase engagement and
enhance behaviour change in children, young people
and families. The aim was for groups of three to four
families to attend one module a month, over a 4-month
period. The intervention was modiﬁed from a
psychology-led clinical intervention which improved
HbA1c by 1.5% (16 mmol/mol) in a non-randomized
controlled pilot.11 Each module was designed to
develop conﬁdence in managing different aspects of dia-
betes, including how to adapt the amount of insulin
taken, how to eat normally and how to manage daily
challenges such as exercise and illness. The curriculum
conformed to the agreed core content for education
programmes set out by the T1D Education Network and
Diabetes UK.
Module 1: the relationship between food, insulin and
blood glucose
Module 1 provides educators with notes about carbohy-
drate foods, blood glucose and a healthy diet, and inter-
national guidelines on nutritional management in
childhood and adolescent diabetes.19 The introduction
helps educators and families identify strengths, resources
and abilities. Families identify how things will be in the
future if they get what they want from CASCADE and
scale how close they currently are to this. The session
focuses on understanding different food groups, particu-
larly carbohydrate. It talks about the role of insulin and
different kinds of insulin regimens. Families and young
people are encouraged to consider the pros and cons of
matching insulin to food to attain better glycemic
control.
Module 2: blood glucose testing
Reading for module 2 are the implications of the
Diabetes Care and Complications Trial (DCCT)20 and
assessment and management of hypoglycemia in chil-
dren and adolescents.21 After reviewing the previous
module educators discuss the recommended target
HbA1c. The group identiﬁes factors which cause BG to
rise and fall and explored how individuals deﬁne hypo-
glycemia, reviewing symptoms according to severity.
Families discuss ways to treat hypoglycemia and assess
the pros and cons of BG testing.
Module 3: adjusting insulin—pros and cons
Reading for module 3 is on insulin analogs in diabetes
care,22 using carbohydrate counting23 and guidelines on
assessment and monitoring of glycemic control.24
Families discuss the symptoms of hyperglycemia and
the signiﬁcance of ketones. A brainstorming session con-
siders when and how and who to contact for help man-
aging hyperglycemia. The group focuses on managing
high BG levels using temporary insulin changes and how
to calculate correction doses. The group explores the
advantages of identifying trends in relation to perman-
ent insulin dose changes. The ﬁnal exercise considers
the advantages and disadvantages of carbohydrate
counting as a way of improving glycemic control.
Module 4: living with diabetes
Guidelines on exercise25 are provided with a set of train-
ing slides from the workshop to explain the principles of
exercise and management of insulin and carbohydrates.
Families identify the effect that low and high blood
glucose levels have on performance and concentration
and discuss strategies they already use to bring BG levels
into target range before starting activity.
Family groups identify how different activities affect
BG levels and discuss the timing of insulin injections in
relation to activity. Young people discuss the advantages
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of using carbohydrate before, during and after exercise
(to keep their BG stable during different kinds of
activity).
At the end of module 4, young people and families
complete a ‘blueprint for success’. This marks the end
of the sessions and acknowledges the steps into the
future the young person has already made. It creates an
opportunity to review the programme and strengthens
long-term motivation to change by reviewing previous
successful goals.
The two main psychological approaches used in the
delivery of CASCADE are MI and SF. Speciﬁc compo-
nents of each approach were incorporated into each
module to enhance engagement and develop conﬁ-
dence and motivation to change. The following techni-
ques were integrated throughout each module.
Communication skills: focusing on positive solutions:
identifying skills abilities and strengths;26 encouraging
families and children to identify previous successes;
describing ongoing positive developments; focusing on
the future; scaling; considering the pros and cons of
behavior change; establishing the importance and conﬁ-
dence of change;27 using ‘scaffolding’ to help indivi-
duals discover information for themselves.28 Additional
learning is a collaborative effort between individuals and
trainers reducing the sense of an expert imposing knowl-
edge and moving toward a shared venture. This active
rather than passive approach has been shown to be
effective in eliciting behavior change in other areas.29
The manual also included training on running groups
that was presented in the workshops.
Two members (DC and RT) taught eight 2-day work-
shops that included MI and SF principles as well as the
content and delivery of the four modules to a
minimum of two educators per intervention site. Each
site sent the required minimum of one pediatric clin-
ical nurse specialist plus another member of the dia-
betes team with some sites sending more than two. A
total of 43 staff attended over a number of weeks. Staff
from a minimum of one clinic and a maximum of
three were trained together in each workshop. A few
sites found it challenging to ‘free up’ staff to attend. A
detailed intervention manual and resources were pro-
vided.30 The training was designed to increase daily use
of behavior change techniques and improve communi-
cation in healthcare encounters with patients as well as
greater consideration of emotional as well as physical
needs of young people and the social constraints of
family life.
The intervention groups could be offered during
standard clinic times or at different times of the day or
week depending on what resources were available to the
clinical teams. The educators were encouraged to be as
ﬂexible as possible within the remit of their job plans.
Advice on organizing groups was also available from the
research team. Most groups were offered in the clinic
during normal clinic hours with a small number offered
in a community space out of hours. Further details on
the issues and challenges faced by clinic staff in interven-
tion delivery are described in Christie et al.30
Controls
Standard care was provided by the control sites. This
involved regular clinic visits to normal clinics and
appointments with nursing staff and other clinic staff as
clinically indicated or requested by families. The speciﬁc
number of appointments, who patients were seen by and
how much contact was available varied signiﬁcantly
across sites.30
Patients and trial design
We undertook a pragmatic cluster-randomized con-
trolled trial with pediatric diabetes clinic as the unit of
randomization with integral process and economic eva-
luations.18 Eligible clinics were National Health Service
(NHS) pediatric diabetes services in London, the South
East and Midlands of England, staffed by at least one
pediatrician and pediatric nurse, which were not
running group education at time of recruitment and
had not taken part in a similar trial within the past
12 months.
Children and young people (8–16 years old) with T1D
and a mean 12-month HbA1c of 8.5% (69 mmol/mol)
or above were eligible to participate. Young people were
excluded if they had (1) a signiﬁcant learning disability
or mental health problems unrelated to diabetes requir-
ing mental health treatment, (2) signiﬁcant other
chronic illness in addition to diabetes and (3) insufﬁ-
cient command of English to enable full participation in
the intervention.
Clinics wrote to the parent/guardian of all eligible
patients before they were approached in clinic.
Informed written consent or assent was obtained for par-
ticipation from both the young person and parent/
carer. Families were offered £10 at both the 12-month
and 24-month data collection points as thanks for par-
ticipation. The study was approved by the Research
Ethics Committee of University College London
Hospital.
Outcomes collected
Primary outcome
The primary trial outcome was change in DCCT aligned
HbA1c measured at baseline, 12 and 24 months after
the baseline blood sample. Samples were sent to a single
UK laboratory to ensure direct comparability of results
from all clinics. Results were reported directly to the
data manager following adjustment against the DCCT
international standard.
Secondary outcomes
Speciﬁc versions of questionnaires were created for: 8–
12, 13–16 years olds and carers with a modiﬁed version
for those on pump therapy. Service user perspectives
were sought on the structure and content of all the
questionnaires. Demographic information and clinical
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data included years since diagnosis, insulin type, dose,
number of injections and time at current clinic. Carer
outcomes included demographic information (age,
gender, ethnic origin, home ownership and deprivation
score).
Psychosocial outcomes
Parental and self-report of health-related QOL was mea-
sured using the generic and diabetes module of the
Pediatric Quality of Life Inventory (PedsQL).31 The
generic module generates a psychosocial and physical
health summary score. The psychosocial score is based
on questions about emotional social and school func-
tioning. The diabetes module generates ﬁve scores
looking at problems with symptoms (diabetes) problems
with injections, following the care plan or getting embar-
rassed (treatment I) carrying out diabetes-related tasks
(treatment II) worrying about the effects of diabetes
(worry) and communicating about diabetes. The
ﬁve-item ‘Impact Supplement’ of the Strengths and
Difﬁculties Questionnaire (SDQ; parent and child
report versions) assessed the impact of identiﬁed emo-
tional and behavioral difﬁculties on the young person’s
life.32 Responsibility for diabetes management was
recorded using the Diabetes Family Responsibility
Questionnaire (DFRQ).33 The number and severity of
hypoglycemic episodes, hospital admissions, service util-
ization, clinic attendance, and contacts were collected
through case note review after the 24-month data collec-
tion point.
Randomization of sites
Clinics were randomly allocated using a schedule drawn
up by the Clinical Trial Unit at the London School of
Hygiene and Tropical Medicine. Allocation was con-
cealed until after clinics had consented and a ﬁrst par-
ticipant recruited to minimize selection biases at entry
of clusters to the trial. Randomization was in a 1:1 ratio
and minimized by factors likely to inﬂuence clinic mean
HbA1c (ie, age of target population of the clinic (pedi-
atric or adolescent), degree of clinic specialization (dis-
trict general hospital clinic or teaching hospital/tertiary
clinic) and size of clinic. Staff were requested not to
inform families about randomization status until recruit-
ment had ﬁnished. The patient’s general practitioner
was informed that their patient was taking part in a trial
and which arm the hospital had been randomized to.
The central laboratory assessing primary outcome
(HbA1c, see below) remained blind to participant
allocation.
Sample size
A sample size of 308 patients from 28 clinics would
enable the trial to detect a difference between group
HbA1c of 0.5 SDs, that is, 0.75% (8 mmol/mol) with
87% power at a signiﬁcance level of 0.05 (two-tailed).
Our initial sample size calculation was based on a SD of
Hb1Ac in the target population of ∼1.5%. (16 mmol/mol)
We proposed to recruit sufﬁcient young people to allow the
trial to detect a difference between groups of 0.5 SDs, that
is, 0.75% (8 mmol/mol) with 90% power at a signiﬁcance
level of 0.05 (two-tailed) and assumed an intracluster correl-
ation coefﬁcient (ICC) of 0.1. With these assumptions, 13
clinics in each arm with an average of 20 young people in
each would be required. Given the possible loss to follow-up
of ∼10%, the target recruitment was inﬂated to 22 young
people from each clinic. However, based on initial within-
clinic recruitment rates of 25% and lower than expected
numbers of eligible patients per clinic, we revised our calcu-
lations based on recruiting 11 patients per clinic, and
include the recruitment of two additional clinics. The
revised calculations are based on an ICC (estimated from
available baseline data (168 participants)) of 0.01.
Analyses
The primary analysis was an intention-to-treat compari-
son. All analyses of continuous outcomes used analysis
of covariance to adjust for the baseline measure of the
outcome in question and speciﬁed a random effect of
clinic to account for clustering at that level. As most sec-
ondary outcomes were highly skewed, 95% CIs for these
measures were estimated using 2000 bootstrap samples.
For binary outcomes, mixed-effects logistic regression,
adjusted for baseline measures where possible, was used
to estimate the effect of the intervention. As there was
no differential attrition by arm and no reason to believe
the data were missing not at random, all analyses used
complete case analysis.
Prespeciﬁed subgroup analyses included age (pediat-
ric/adolescent), gender, high/low baseline levels of
HbA1c (<10.4% (90 mmol/mol) vs ≥10.4% (90 mmol/
mol)) and socioeconomic status (as measured by the
multiple deprivation score) and effect sizes and 95% CIs
estimated from models that included an interaction
term.
A per protocol analysis of all primary and secondary
outcomes was carried out with adherence to the proto-
col being deﬁned as attending three or more of four
CASCADE sessions. The same statistical analysis techni-
ques were used as for the intent-to-treat analysis.
Serious adverse events (SAEs) were reported by par-
ticipating sites; assessment of seriousness, causality and
expectedness relating to the CASCADE intervention was
carried out by a clinically trained member of the
research team blind to allocation. SAEs were also
recorded during the case note review.
The Data Monitoring and Ethics Committee conﬁden-
tially reviewed unblinded interim analyses on three occa-
sions and did not recommend stopping the trial early.
Process evaluation
A mixed-methods approach was used in the integral
process evaluation. Questionnaires, semistructured inter-
views, non-participant informal discussion following
observation sessions, ﬁeldwork notes, and case note
review were employed to collect qualitative and
4 BMJ Open Diabetes Research and Care 2016;4:e000165. doi:10.1136/bmjdrc-2015-000165
Clinical care/education/nutrition/psychosocial research
quantitative data from key stakeholder groups
(University College London Hospital trainers, site educa-
tors, young people and parents) at speciﬁc time points
in the trial.
The process evaluation was designed to assess the
feasibility and acceptability and ﬁdelity of delivering
CASCADE groups as part of standard care within a NHS
setting. Should the CASCADE intervention fail to be
effective, the process evaluation was designed to assess
the extent to which theory or implementation was
responsible.
Economic analyses
The economic evaluation compared the CASCADE
intervention to current NHS practice. Assessment of
CASCADE cost-effectiveness with respect to current
NHS practice focused on the cost of delivering the inter-
vention and on the relative success controlling HbA1c
and predicted impact on diabetic complications over
time.34 The cost-effectiveness model considered long-
term cost and beneﬁt implications of delaying onset of
microvascular and macrovascular diabetic complications
by comparing HbA1c in the intervention and control
groups.
RESULTS
In total, 1340 eligible patients were identiﬁed and sent
information about the study; 1177 attended clinic
appointments and were approached and invited to take
Figure 1 Consort diagram showing flow of clinics and young people through the trial.
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part; 365 patients were recruited between February 2009
and September 2010, that is, 27% of those eligible.
Reasons for declining to participate included lack of
time and dislike of giving venous blood samples. Three
patients were recruited with ineligible HbA1c levels and
were excluded from further analysis, leaving 362 as the
ﬁnal sample. Figure 1 shows the ﬂow of clinics and
young people through the trial.
Demographic information on the 28 clinics and on
the 327 children and young people and 324 parents
who completed the baseline questionnaire is shown in
table 1. The two groups were comparable at trial entry
with all clinics mixed with regards to age; 86% in each
arm were general hospital clinics with comparable
numbers of eligible patients in each arm. Primary and
secondary outcome measures outcomes by study arm at
baseline are shown in table 2. The two arms appear well
balanced at baseline for all outcomes. We did not test
for baseline differences as we comply with CONSORT
guidelines35 that advise against statistical testing of differ-
ences between randomized groups that are most likely
caused by chance.
Ninety-six of the 180 young people recruited to the
intervention arm (53%) attended at least one CASCADE
module. There were no signiﬁcant differences in attend-
ance by gender, duration of diabetes, ethnicity or level
of deprivation in the area in which they lived.
Eighty-four young people (47%) failed to attend any
modules. Seven (4%) dropped out of the study before
the CASCADE modules were offered in their clinic, 11
(6%) were never offered modules to attend, and 66
(37%) were offered the opportunity to attend the
modules, but opted not to do so. The main reason for
opting out was desire not to miss school or other
activities.
The primary outcomes at 12 and 24 months are shown
in table 3. The mean HbA1c at 12 months was 10.2%
(88 mmol/mol) in the intervention group and 10.1%
(87 mmol/mol) in the control group with an estimated
adjusted mean difference of 0.11 (95% CI −0.28 to
0.50). The ICC for the primary outcome at 12 months
was 0.134 and 0.060 at 24 months.
Table 1 Baseline characteristics of clinics, young people
and parents/carers
Intervention Control
Clinics N=14 N=14
Age profile of patients*
Pediatric (0–12); n (%) 0 0
Adolescent (13–18);
n (%)
0 0
Mixed; n (%) 14 (100) 14 (100)
Type of clinic*
General hospital; n (%) 12 (86) 12 (86)
Specialist/tertiary; n (%) 2 (14) 2 (14)
Number of eligible patients**
≤32 6 (43) 4 (28)
33 to 50 5 (36) 5 (36)
>50 3 (21) 5 (36)
Size of clinic
Number attending clinic;
mean (SD)
122 (45.8) 140 (51.3)
More than 50 young
people registered; n (%)
14 (100) 14 (100)
More than 100 young
people registered; n (%)
11 (79) 9 (64)
Staffing
f/t DSN or equiv; n (%) 14 (100) 14 (100)
Dietician support; n (%) 13 (93) 13 (93)
Young people N=159 N=168
Gender
Female; n (%) 91 (57.2) 90 (53.6)
Male; n (%) 68 (42.8) 78 (46.4)
Age (years); mean (SD) 13.1 (2.1) 13.2 (2.1)
Ethnicity
White British; n (%) 133 (83.7) 129 (76.8)
White other; n (%) 5 (3.1) 5 (3.0)
Mixed; n (%) 7 (4.4) 4 (2.4)
Asian/Asian British; n (%) 5 (3.1) 14 (8.3)
Black/black British; n (%) 5 (3.1) 6 (3.6)
Chinese; n (%) 0 0
Other; n (%) 4 (2.5) 9 (5.4)
Time since diagnosis
(years); mean (SD)
5.7 (3.2) 6.1 (3.3)
Time since enrolled at
participating clinic (years);
mean (SD)
5.1 (2.9) 5.6 (3.2)
Parents/carers N=156 N=169
Gender
Female; n (%) 137 (87.8) 151 (89.4)
Male; n (%) 19 (12.2) 17 (10.1)
Relationship to young person with diabetes
Mother; n (%) 136 (87.2) 153 (90.5)
Father; n (%) 17 (10.9) 13 (7.7)
Female guardian; n (%) 0 1 (0.6)
Male guardian; n (%) 0 0
Other; n (%) 2 (1.3) 0
Partnership status
Married; n (%) 89 (57.1) 113 (66.9)
Cohabiting: n (%) 18 (11.5) 18 (10.7)
Single parent; n (%) 45 (28.9) 36 (21.3)
Ethnicity
White British; n (%) 135 (86.5) 132 (78.1)
Continued
Table 1 Continued
Intervention Control
Clinics N=14 N=14
White other; n (%) 7 (4.5) 5 (3.0)
Mixed; n (%) 0 2 (1.2)
Asian/Asian British; n (%) 6 (3.9) 15 (8.9)
Black/black British; n (%) 4 (2.6) 5 (3.0)
Chinese; n (%) 1 (0.6) 1 (0.6)
Other; n (%) 3 (1.9) 8 (4.7)
Tenure
Privately owned; n (%) 106 (68.0) 98 (58.0)
Council/rented; n (%) 48 (30.8) 68 (40.2)
Deprivation score mean
(SD)
21.01 (13.1) 21.98 (15.58)
6 BMJ Open Diabetes Research and Care 2016;4:e000165. doi:10.1136/bmjdrc-2015-000165
Clinical care/education/nutrition/psychosocial research
The secondary outcomes as reported by the partici-
pants and their carers at 12 and 24 months are shown in
tables 4 and 5. Outcomes were similar between the two
arms of the trial.
A per protocol analysis was performed including only
intervention participants who had attended 3–4 of the 4
modules (n=55). This also found no difference in
HbA1c between arms.
A number of prespeciﬁed subgroup analyses were
carried out. The analysis of baseline HbA1c suggested
that among those with HbA1c levels ≥10.4% (90 mmol/
mol) at baseline, HbA1c levels at follow-up were greater
in the intervention than the control arm, suggesting that
those with higher HbA1c responded more poorly to the
CASCADE intervention. This difference was statistically
signiﬁcant at 12 months but not at 24 months. There
Table 2 Diabetes knowledge, confidence and management at baseline
Young person Parent/carer
Intervention
N=159
Control
N=168
Intervention
N=156
Control
N=169
Management
HbA1c (venepuncture)
Mean (%) (SD) 9.9% (1.5) 10.0% (1.5) – –
Mmol/mol mean (SD) 85 mmol/mol (16) 86 mmol/mol (16)
Number of severe hypoglycemic episodes in last month; n (%)*
1 12 (7.6) 13 (7.8)
2 2 (1.3) 2 (1.2)
3 1 (0.6) 1 (0.6)
12 1 (0.6) 0
Number of times admitted in past 6 months; n (%)*
1 23 (14.7) 16 (9.5)
2 0 2 (1.2)
3 1 (0.6) 1 (0.6)
10 1 (0.6) 0
Number of times attended diabetes clinic in
last year; median (IQR)
4.0 (3.5, 4.0) 4.0 (3.5, 4.0)
Visit hospital doctor most/every visit; n (%) 130 (89.0) 142 (88.8)
Visit diabetes nurse most/every visit; n (%) 139 (92.1) 158 (95.8)
Visit dietician occasionally or more often;
n (%)
129 (92.1) 129 (84.9)
Visit psychologist occasionally or more
often; n (%)
16 (14.7) 19 (15.5)
PedsQL—general; median (IQR)
Physical health summary score 90.6 (84.4, 96.9) 90.6 (81.3, 96.9) 89.1 (78.6, 93.8) 87.5 (78.1, 96.9)
Psychosocial health summary score 83.9 (75.0, 91.7) 81.7 (70.0, 90.0) 76.7 (63.8, 86.7) 75.0 (61.7, 85.0)
Total score 87.0 (76.1, 92.4) 84.8 (75.0, 91.3) 79.3 (70.1, 89.1) 80.4 (68.5, 88.0)
PedsQL—diabetes module; median (IQR)
Diabetes score 62.5 (50.0, 77.3) 61.4 (50.0, 72.7) 56.8 (45.5, 68.2) 54.5 (43.2, 65.9)
Treatment 1 score 75.0 (62.5, 87.5) 81.3 (62.5, 93.8) 62.5 (43.8, 75.0) 62.5 (50.0, 75.0)
Treatment 2 score 85.7 (75.0, 92.9) 87.5 (71.4, 96.4) 78.6 (65.0, 89.3) 75.0 (64.3, 91.7)
Worry score 75.0 (50.0, 91.7) 75.0 (58.3, 91.7) 66.7 (50.0, 83.3) 66.7 (50.0, 83.3)
Communication score 75.0 (50.0, 91.7) 83.3 (66.7, 100.0) 66.7 (50.0, 100.0) 75.0 (50.0, 100.0)
Diabetes family responsibility questionnaire; median (IQR)
Family responsibility total score 35.0 (31.0, 38.3) 36.0 (32.0, 39.0) 31.0 (27.5, 35.0) 31.8 (28.0, 35.0)
Strengths and difficulties questionnaire; median (IQR)
Strengths and difficulties total average impact
score
0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
Normal; n (%) 139 (89.1) 145 (89.0) 126 (81.8) 138 (82.1)
Borderline; n (%) 2 (1.3) 3 (1.8) 4 (2.6) 5 (3.0)
Abnormal; n (%) 15 (9.6) 15 (9.2) 24 (15.6) 25 (14.9)
Body weight and insulin; median (IQR)
Happiness with body weight 8.0 (5.0, 9.0) 7.0 (4.0, 9.0) – –
Number of times skipped insulin in last
month; median (IQR)
0 (0, 2) 0 (0, 2) – –
Ever skipped insulin to lose weight; n (%) 8 (5.0) 9 (5.4) – –
*Data provided by case note review.
PedsQL, Pediatric Quality of Life Inventory.
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was no evidence that results differed according to age,
gender or deprivation score
Serious adverse events
Seven SAEs were reported in the intervention arm and
13 in the control arm during the study period. Despite
reporting procedures being reviewed during the trial, it
was recognized that fewer than expected SAEs were
being reported. The case note re view data reported a
total of 145 SAEs in the intervention arm and 187 in the
control arm.
Process evaluation
In every site, it proved feasible to train nurses and dieti-
cians to be site educators; however, staff found organiz-
ing the groups burdensome in terms of arranging
suitable dates/times and creating satisfactory group com-
position in the absence of dedicated administration time
and skills. As a result, the intervention was not delivered
to a large proportion of participant patients. Only 12 of
the 14 sites delivered at least one complete group of
four modules. Only 68% of possible groups were run.
This was due to poor uptake from families after recruit-
ment and baseline data collection and those groups that
did run were smaller in size and more mixed in terms of
ages of participants than intended. Delivering the inter-
vention to these non-ideal groups was challenging. Take
up was particularly low for those young people with the
highest HbA1c. Those who attended had signiﬁcantly
lower mean baseline HbA1c scores than those who did
not attend (9.52% (81 mol/mol) vs 10.33% (89 mmol/
mol), p<0.01).
Of the 180 families in the intervention group, only 55
(30%) received the full programme with 53% attending
at least one module. Signiﬁcantly more children
(8–12 years) attended at least one module compared
with teenagers (13–16 years; 64% vs 44%, p<0.01).
Young people and parents who attended and staff who
delivered CASCADE were enthusiastic about its relevance
and members of all stakeholder groups reported some
perceived impact. Parents and young people who
attended described improvements in family relationships,
knowledge and understanding, greater conﬁdence and
increased motivation to manage diabetes. At 24 months
nearly half of the young people reported the groups had
made them want to try harder with their diabetes and
that they had carried on trying.
Fidelity of content delivery was moderately good,
although consistent use of motivational techniques was
challenging for some site educators. In two sites, staff
that had undergone training left and were replaced by
staff who had not attended the workshops.
Implementation and model factors were further com-
pounded by trial factors—including a smaller than
expected numbers of recruits in some sites and a longer
than planned for time lapse between training and deliv-
ery caused by delays in patient recruitment. For a longer
discussion of these issues see Sawtell et al.36
Economic analysis
The mean cost of providing the intervention was £5098
per site or £683 per child. The lifetime costs of the
CASCADE intervention were estimated to be £216
greater than those of current practice.30 Since there was
no difference in health outcome between the CASCADE
intervention and current practice, the option with the
lowest cost is the most cost-effective.
DISCUSSION
We evaluated current best practice in pediatric diabetes
structured education with an additional psychological
component designed to increase engagement and
behavior change in routine care, using robust method-
ology and a diverse population. Despite evidence that
the intervention was popular with staff and with families
that attended, there were challenges in the organization
and delivery of groups alongside standard practice that
are often not acknowledged and as a consequence the
intervention was not delivered to a large proportion of
participant patients. The provision of structured educa-
tion through the CASCADE intervention delivered in
routine NHS care by specialist clinic staff given 2 days
standardized training failed to demonstrate improved
Table 3 HbA1c from venepuncture at 12 and 24 months follow-up
Intervention Control Intervention effect
N Mean (SD) N Mean (SD)
Estimate (95% CI)
p Value
12-month follow-up
HbA1c (%) at 12 months
Mmol/mol (SD)
143 10.2% (2.0)
88 mmol/mol (21)
155 10.1% (1.6)
87 mmol/mol (17)
0.11 (−0.28 to 0.50)
p=0.584
Change in HbA1c at 12 months from baseline 137 0.38 (1.34) 144 0.28 (1.27)
24-month follow-up
HbA1c (%) at 24 months 135 10.1% (1.9)
87 mmol/mol (20)
149 10.0% (1.7)
86 mmol/mol (18)
0.03 (−0.36 to 0.41)
p=0.891
Change in HbA1c at 24 months from baseline 129 0.10 (1.52) 138 0.07 (1.53)
HbA1c, glycated hemoglobin.
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Table 4 Diabetes knowledge, confidence and management at 12 months follow-up
Young person Parent/carer
Intervention Control Intervention Intervention Control Intervention
Median (IQR) Median (IQR) Effect (95% CI) Median (IQR) Median (IQR) Effect (95% CI)
Regimen
Number of injections per day 4.0 (4.0, 4.0) 4.0 (4.0, 4.0) 0.08 (−0.22 to 0.34)
Average total dose of quick acting insulin
per day
30.0 (22.0, 42.0) 25.5 (16.0, 37.0) 5.06 (1.04 to 9.93)
Average total dose of slow acting insulin
per day
30.0 (22.0, 42.0) 26.5 (15.5, 36.0) 4.94 (0.61 to 9.16)
Management
Number of severe hypoglycemic episodes in last month; n (%)
1 9 (6.3) 11 (7.1) 0.76* (0.35 to 1.67)
2 2 (1.4) 2 (1.3)
3 1 (0.7) 1 (0.7)
4 0 1 (0.7)
5 0 1 (0.7)
Number of times admitted in past 6 months; n (%)
1 17 (11.9) 14 (9.0) 1.08* (0.54 to 2.14)
2 2 (1.4) 2 (1.3)
6 0 1 (0.7)
8 0 1 (0.7)
Number of times attended diabetes clinic in
last year
4.0 (3.5, 4.0) 4.0 (3.5, 4.0) 0.01 (−0.22 to 0.24)
Visit hospital doctor most/every visit; n (%) 127 (93.4) 127 (90.1) 2.71 (0.81 to 9.05)
Visit diabetes nurse most/every visit; n (%) 128 (91.4) 143 (95.3) 0.68 (0.22 to 2.05)
Visit dietician occasionally or more often;
n (%)
121 (91.7) 122 (90.37) 1.64 (0.53 to 5.06)
Visit psychologist occasionally or more
often; n (%)
19 (20.2) 12 (11.0) 3.64 (0.56 to 23.63)
Pedsq1—general; median (IQR)
Physical health summary score 90.6 (84.4, 96.9) 88.4 (78.1, 96.9) 0.34 (−2.51 to 2.62) 90.6 (81.3, 96.9) 87.5 (71.9, 93.8) 2.24 (−1.34 to 5.10)
Psychosocial health summary score 81.7 (70.0, 88.3) 81.7 (71.4, 90.0) −1.85 (−4.29 to 0.24) 78.3 (63.3, 88.3) 71.7 (58.3, 83.3) 1.76 (−1.50 to 5.79)
Total score 83.7 (76.1, 90.2) 82.6 (75.0, 89.1) −1.09 (−3.15 to 0.63) 82.6 (70.7, 89.1) 77.2 (63.0, 85.9) 1.74 (−1.14 to 5.00)
PedsQL—diabetes module; median (IQR)
Diabetes score 61.4 (51.1, 72.7) 61.4 (50.0, 70.5) 0.62 (−2.35 to 3.04) 56.8 (50.0, 70.5) 54.5 (40.9, 65.9) 1.13 (−1.72 to 4.02)
Treatment 1 score 75.0 (56.3, 87.5) 81.3 (62.5, 93.8) −0.80 (−5.14 to 3.08) 62.5 (50.0, 81.3) 62.5 (50.0, 81.3) 0.79 (−2.58 to 4.10)
Treatment 2 score 85.7 (75.0, 92.9) 87.5 (75.0, 96.4) −1.90 (−4.99 to 1.97) 82.1 (64.3, 92.9) 75.0 (62.5, 89.3) 2.37 (−0.40 to 5.37)
Worry score 75.0 (58.3, 91.7) 75.0 (58.3, 91.7) −0.77 (−5.43 to 3.94) 75.0 (50.0, 91.7) 66.7 (50.0, 83.3) 3.59 (−1.50 to 7.57)
Communication score 75.0 (58.3, 91.7) 79.2 (58.3, 91.7) −1.34 (−6.31 to 4.01) 75.0 (50.0, 100.0) 75.0 (50.0, 100.0) 2.30 (−2.44 to 8.64)
Diabetes family responsibility questionnaire; median (IQR)
Family responsibility total score—young
person (weighted*†)
36.0 (32.9, 39.0) 36.0 (32.6, 40.0) 0.01 (−0.85 to 0.81) 33.0 (29.0, 36.0) 32.5 (29.0, 36.0) 0.62 (−0.17 to 1.47)
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diabetes control in children and adolescents with poor
glycemic control.
Our ﬁndings may reﬂect a lack of effectiveness of the
CASCADE intervention or a lack of intervention ‘reach’
in this pragmatic trial, possibly due to multiple factors.
Despite extensive efforts by the intervention clinics to
offer groups at times that suited young people and fam-
ilies non-response and failure to attend rates were high.
Only 53% of participants in the intervention arm
received any intervention sessions. In the main, delivery
issues were pragmatic issues related to lack of administra-
tive support for intervention delivery within routine clin-
ical services. One clinic was only able to deliver one out
of the four group sessions and one clinic failed to
deliver any groups. Second, the intervention was deliv-
ered by clinic nurses and dietitians after a relatively brief
training, whereas in the pilot delivery was by qualiﬁed
psychologists working alongside senior nursing staff. The
varied ﬁdelity in delivery of content and in particular
speciﬁc motivational techniques suggests the training
was insufﬁcient for the skill level of the staff involved.
Other studies have shown that nurses and dietitians can
be successfully trained to use MI with nurses seeing this
approach as consistent with their values and better than
traditional advice-giving approaches.37
MI can appear to be a deceptively simple approach;
however, while some of the concepts are straightforward
to grasp intellectually, the skilful practice of MI takes
time, effort and responsiveness to regular feedback as
well as requiring appropriate training. Difﬁculty in deliv-
ery of key motivational components also suggests there
was a need for ongoing supervision to ensure quality of
delivery to families. In some cases there was also a
failure to deliver the interventions as recommended.
One site used an untrained member of staff as the
second trainer in one module (and no second trainer in
the other modules)—another site had partially trained
staff ‘supporting’ sessions despite clear recommendation
that training in delivery was necessary. Finally, the
process evaluation raised issues about questions about
timing (the intervention may have been more effective
closer to diagnosis) and targeting. It might be argued
that the intervention may have been more effective if
aimed at with children with lower HbA1c and earlier in
their diabetes history.36
The negative outcome of this trial must be examined
in the context of other recent negative trials of psycho-
social interventions in pediatric diabetes in the UK.
Common characteristics of these trials (including
CASCADE) were that (1) each offered a single interven-
tion to improve glycemic control, and (2) each
attempted to extend the role of existing diabetes
nursing and medical staff to either deliver psychologic-
ally based interventions or deliver elements of routine
care in ways informed by psychological theories such as
MI. Together these trials suggest strongly that such
approaches may be ineffective in improving diabetes
control, particularly where control is already poor.38–41
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Table 5 Diabetes knowledge, confidence and management at 24 months follow-up
Young person Parent/carer
Intervention
N=144
Control
N=151 Intervention effect
Intervention
N=137
Control
N=140 Intervention effect
Median (IQR) Median (IQR)
Estimate effect
(95% CI) Median (IQR) Median (IQR)
Estimate effect
(95% CI)
Regimen
Number of injections per day 4.0 (4.0, 4.0) 4.0 (4.0, 4.0) −0.14 (−0.43 to 0.15)
Average total dose of quick acting insulin
per day
34.0 (25.0, 50.0) 30.0 (18.0, 40.0) 6.87 (1.26 to 12.57)
Average total dose of slow acting insulin
per day
29.0 (22.0, 42.0) 27.5 (19.0, 34.5) 5.85 (1.58 to 9.73)
Management
Number of severe hypoglycemic episodes in last month; n (%)
1 6 (4.4) 7 (5.0) 0.92* (0.32 to 2.59
2 1 (0.7) 3 (2.1)
3 3 (2.2) 1 (0.7)
Number of times admitted in past 6 months; n (%)
1 11 (8.0) 12 (8.6) 0.95* (0.46 to 1.96)
2 2 (1.5) 3 (2.1)
3 2 (1.5) 1 (0.7)
4 1 (0.7) 0 (0.0)
6 0 (0.0) 1 (0.7)
Number of times attended diabetes clinic
in last year
4.0 (3.0, 4.0) 4.0 (3.5, 4.0) −0.18 (−0.41 to 0.06)
Visit hospital doctor most/every visit;
n (%)
121 (93.8) 115 (85.8) 3.09 (1.07 to 8.91)
Visit diabetes nurse most/every visit;
n (%)
125 (94.7) 122 (90.4) 2.70 (0.92 to 7.92)
Visit dietician occasionally or more often;
n (%)
118 (92.2) 106 (85.5) 2.26 (0.86 to 5.93)
Visit psychologist occasionally or more
often; n (%)
27 (25.5) 14 (12.8) 3.85 (0.77 to 19.31)
PedsQL—general
Physical health summary score 90.6 (81.3, 96.9) 87.5 (81.3, 96.9) 1.14 (−1.28 to 3.32) 87.5 (81.3, 93.8) 87.5 (71.9, 93.8) 2.00 (−2.04 to 5.29)
Psychosocial health summary score 80.0 (68.3, 88.3) 81.7 (71.7, 88.3) −1.17 (−3.69 to 1.45) 75.0 (63.3, 88.3) 73.3 (61.7, 84.2) 0.03 (−3.08 to 3.66)
Total score 83.7 (75.0, 90.2) 84.2 (75.0, 90.2) −0.33 (−2.53 to 1.97) 77.2 (69.6, 90.2) 77.2 (66.3, 87.0) 0.58 (−2.70 to 3.46)
PedsQL—diabetes module
Diabetes score 63.6 (50.0, 75.0) 63.6 (54.5, 75.0) −0.02 (−3.19 to 2.72) 56.8 (47.7, 68.2) 56.8 (45.5, 71.6) −0.08 (−2.83 to 3.12)
Treatment 1 score 75.0 (62.5, 87.5) 81.3 (62.5, 93.8) −1.05 (−4.52 to 2.32) 68.8 (50.0, 81.3) 62.5 (50.0, 81.3) 2.20 (−2.31 to 6.88)
Treatment 2 score 85.7 (71.4, 95.8) 85.7 (75.0, 95.8) −1.49 (−4.53 to 1.42) 78.6 (64.3, 89.3) 78.6 (64.3, 92.9) −1.10 (−4.49 to 2.50)
Worry score 75.0 (58.3, 87.5) 75.0 (58.3, 91.7) −0.32 (−4.64 to 4.52) 66.7 (50.0, 83.3) 66.7 (50.0, 89.6) 0.66 (−3.75 to 5.14)
Communication score 83.3 (58.3, 91.7) 83.3 (66.7, 100.0) −1.06 (−5.34 to 3.59) 75.0 (50.0, 100.0) 83.3 (50.0, 100.0) −2.54 (−9.06 to 4.16)
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Table 5 Continued
Young person Parent/carer
Intervention
N=144
Control
N=151 Intervention effect
Intervention
N=137
Control
N=140 Intervention effect
Median (IQR) Median (IQR)
Estimate effect
(95% CI) Median (IQR) Median (IQR)
Estimate effect
(95% CI)
Diabetes family responsibility questionnaire
Family responsibility total score—young
person (weighted *†)
38.0 (34.0, 41.0) 37.0 (34.0, 42.0) 0.71 (−0.07 to 1.44) 35.0 (31.9, 38.0) 34.0 (30.0, 38.5) 0.60 (−0.43 to 1.47)
Dyadic parent–child responsibility pattern – – – 0 (0, 1) 0 (0, 1) −0.03 (−0.26 to 0.23)
Strengths and difficulties questionnaire
Strengths and difficulties total average
impact score
0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.04 (−0.14 to 0.21) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) −0.09 (−0.41 to 0.26)
Normal; n (%) 130 (91.6) 135 (89.4) – 110 (82.7) 107 (77.0) –
Borderline; n (%) 2 (1.4) 4 (2.7) 2 (1.5) 6 (4.3)
Abnormal; n (%) 10 (7.0) 12 (8.0) 21 (15.8) 26 (18.7)
Body weight and insulin
Happiness with body weight 7.0 (4.0, 9.0) 7.0 (5.0, 9.0) −0.56 (−1.03 to −0.06) – – –
Number of times skipped insulin in last
month
0 (0, 2) 0 (0, 2) 1.30* (0.78 to 2.17) – – –
Ever skipped insulin to lose weight; n (%) 5 (3.5) 7 (4.6) 0.72 (0.22 to 2.33) – – –
*OR for once or more versus none.
†Weighted to allow for non-response.
PedsQL, Pediatric Quality of Life Inventory.
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Our ﬁndings add to this by suggesting that attempting
to deliver psychologically informed structured education
is not a useful remedy for poor diabetes control in chil-
dren and adolescents if offered in routine clinical prac-
tice by diabetes specialist nurses or dietitians. It is
important to note that our trial did not assess the value
of routine structured education in newly diagnosed dia-
betes, and it is imperative that our ﬁndings are not gen-
eralized to those newly diagnosed.
CONCLUSIONS
Signiﬁcant challenges were encountered in the delivery
of a structured education intervention using psycho-
logical techniques by diabetes nurses and dietitians in
routine clinical practice. The intervention did not
improve HbA1c in children and adolescents with poor
control. Our ﬁndings suggest that the provision of struc-
tured education in pediatric diabetes care, now man-
dated in the UK and a requisite for insurance payment
in Germany will not improve diabetic control in those
with poor control. However, structured education
should remain as a basic pre-requisite for care of all
children and young people newly diagnosed with dia-
betes, with further attention given to stepped-care
models, in which interventions tailored to the speciﬁc
needs of the child and family are delivered by more spe-
cialist staff.
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